Creyos

Creyos

Share

Cambridge Brain Sciences is a leading web-based platform for the assessment of cognitive function, built for healthcare practitioners and researchers.

06/05/2026

If it's not in the EHR, it won't scale.

When cognitive assessment results sit in a separate platform, they rarely make it into documentation, care coordination, or population-level reporting.

That's why we built Creyos to integrate directly into Epic.

🏥 In-clinic assessments launch from existing workflows during routine visits
💻 Remote assessments reach patients through MyChart ahead of appointments
📋 Results and reports flow into the patient chart automatically

No new logins, no manual entry, no switching between systems.

For health systems on Epic, cognitive data sits where the rest of the clinical record already does.

Read the full article: https://hubs.li/Q04klPyT0

05/27/2026

💬 The right service, in the right place, at the right time.

Our CEO Marc Lipton heard versions of that framing at industry conferences and executive roundtables in the first half of this year, from payer executives, system CMOs, and primary care leaders.

For cognitive health, the gap between that aspiration and what happens in primary care today is measurable. And it's an infrastructure problem, not an awareness one.

Read Marc's reflection on the Creyos blog: https://hubs.ly/Q04j68j-0

05/19/2026

🧠 Mild cognitive impairment is both common and surprisingly underdetected, particularly in primary care settings where formal cognitive testing often isn't part of the workflow at all.

In a new NeurologyLive interview, Creyos Chief Scientific Officer Adrian Owen, PhD, OBE, discusses the research behind the Creyos Dementia Screener.

Built using machine learning, the screener is designed to flag early signs of cognitive decline in minutes, without requiring specialist training to administer.

Read the full interview: https://hubs.li/Q04hb7P40

05/15/2026

🧠 The AAN Annual Meeting covered a lot of ground. Alzheimer's biomarkers, cognitive care in neurodiverse populations, menopausal brain fog, medication-related impairment.

For our team, one theme stood out across all of it: whether cognitive measurement is keeping pace with what the field needs from it.

Creyos Staff Scientist Sydni Paleczny shares her reflections from the meeting.

🔍 Read her full recap on the Creyos blog: https://hubs.li/Q04gNH4K0

Want your business to be the top-listed Engineering Company in Toronto?
Click here to claim your Sponsored Listing.

Telephone

Address


214 King Street W. Suite 210
Toronto, ON
M5H3S6